News

Press Releases —

European Medicines Agency Confirms Acceptance of Marketing Authorization Application for AVT05, a Proposed Biosimilar to Simponi® (golimumab)

Learn more

Press Releases —

ADVANZ PHARMA Releases Environmental, Social & Governance (ESG) Report for 2023-2024

Learn more

Press Releases —

ADVANZ PHARMA and Enzene Enter an Exclusive Partnership for Biosimilar Development and Commercialisation

Learn more

Press Releases —

European Medicines Agency Confirms Acceptance of Marketing Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)

Learn more

Press Releases —

Alvotech and ADVANZ PHARMA Sign Commercialization Agreement for Proposed Biosimilar to Eylea® LD/HD in Europe

Learn more

Press Releases —

ADVANZ PHARMA and Allecra Therapeutics announce approval in the European Union for the new antibiotic combination EXBLIFEP® (cefepime/enmetazobactam) for the treatment of severe infections

Learn more

Press Releases —

ADVANZ PHARMA receives positive CHMP opinion for EXBLIFEP® (cefepime/enmetazobactam)

Learn more

Press Releases —

ADVANZ PHARMA acquires global rights to Androcur® from Bayer

Learn more

Press Releases —

ADVANZ PHARMA and Dimerix enter into an Exclusive License Agreement to commercialise DMX-200 in Europe, Canada, Australia, and New Zealand

Learn more